Completed PHASE2 INTERVENTIONAL 2-arm NCT01394497

Use of N-Acetylcysteine During Liver Procurement

Infusione Sistemica e Loco-regionale di N-Acetilcisteina Nel Prelievo di Fegato: Uno Studio Prospettico Randomizzato Controllato. Fase II.

Sponsor: Azienda Ospedaliera di Padova

Conditions Carcinoma, Hepatocellular Liver Diseases Liver Failure Liver Failure, Acute Liver Neoplasms

Interventions N-acetylcystein

Updated 6 times since 2017 Last updated: Feb 15, 2013 Started: Dec 31, 2006 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Carcinoma, Hepatocellular and Liver Diseases, this trial is completed. The trial is conducted by Azienda Ospedaliera di Padova and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera di Padova

Data source: Azienda Ospedaliera di Padova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Padua, Italy